Thrombectomy Devices Market - Strategies Adopted by Top Market Players

According to research report thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period.
The key players focused on various strategies such as product launches and enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase their shares in the global thrombectomy devices market. Product launches & enhancements is the strategy adopted by major industry players to achieve the desired market growth during 2013-2017. This strategy was adopted by Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.). Apart from product launches and enhancements, many prominent players also adopted agreements and collaborations as their key growth strategy to strengthen their market presence, enhance their R&D capabilities, and to expand their distribution networks to generate additional demand by sensitizing end users through an increase in availability of thrombectomy devices.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801
Stryker Corporation held the leading position in the market in 2016. The company offers its thrombectomy devices through the Neurotechnology & Spine segment. The company has a strong presence in North America, Europe, the Middle East, Africa, Asia-Pacific and other countries. The company has more than 30 manufacturing facilities in countries such as the U.S., China, Turkey, Germany, Ireland, Switzerland, and France. It primarily focuses on growth strategies such as product development & commercialization, acquisitions, and market expansions. The market has witnessed several product launches & commercialization, expansions, and acquisitions by Stryker Corporation (U.S.) in the last three years. For instance, in 2016, the company commercialized thrombectomy devices such as Trevo Provue retriever and Trevo XP ProVue retriever, the establishment of its European headquarters in Amsterdam (Netherlands), in 2015, and the acquisition of Trauson Holdings Company Limited (China) in 2013. These developments strengthened its R&D capabilities and expanded its product portfolio in the market.
Medtronic plc is one of the prominent players in the market, in 2016. The company has a strong foothold in the market with a broad range of thrombectomy products. The company has a strong geographic presence across Asia-Pacific, Eastern Europe, Latin America, the Middle East & Africa, Central Asia, Western Europe, South Asia, and North America. To strengthen its current position and to gain a larger share in the market, the company aggressively focuses on growth strategies such as acquisitions and market expansions. During 2012–2016, the company established its training and research facility—Covidien Center of Innovation Brazil—in Brazil and its R&D, training, and education center—Covidien Center of Innovation Korea—in South Korea to enhance its R&D capabilities and expand its product portfolio and market presence in the market. The company also focuses on product commercialization as its business strategy. It commercialized thrombectomy devices such as the Solitaire stent retriever device in 2016 and Solitaire revascularization device in 2012.
Know more: https://www.marketsandmarkets.com/Market-Reports/thrombectomy-devices-market-222966801.html

Forensic Equipment and Supplies Market Top Players and Global Forecast 2024

According to research report the global forensic equipment and supplies market is projected to reach USD 8.7 billion by 2024 from USD 6.0 billion in 2019, at a CAGR of 7.7% during the forecast period. Factors such as the growing number of crimes across major countries, ongoing technological advancements in forensic sciences, growing public-private investments in the field of forensics, and the rising awareness among investigators about the role of DNA profiling in criminology are driving the growth of the forensic equipment and supplies market. However, the high cost of forensic instruments and the dearth of well-skilled technicians to perform forensic analysis in emerging countries are expected to restrain the growth of this market during the forecast period.
The major players operating in the forensic equipment and supplies market include Thermo Fisher Scientific (US), PerkinElmer (US), Agilent Technologies (US), Waters Corporation (US), and SCIEX (Danaher Corporation, US). Other prominent players in this market include GE Healthcare (US), QIAGEN NV (Netherlands), Spectris (UK), Air Science (US), Lynn Peavey Company (US), Sirchie (US), BVDA International (Netherlands), Safariland, LLC (US), Horiba (Japan), and Illumina, Inc. (US). The analysis of market developments between 2014 and 2018 revealed that several growth strategies such as product launches and strategic market expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the forensic equipment and supplies market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=254612639
Thermo Fisher Scientific (US) dominated the market in 2018. The company offers a broad range of forensic equipment and supplies that are used in various applications, such as forensic DNA analysis, forensic toxicology, and blood analysis. The company has a strong geographic presence across North America, Europe, the Asia Pacific, Africa, and the Middle East. Thermo Fisher mainly focuses on the development of technologically innovative products to further strengthen its position in the market. For instance, the company launched Vanquish UHPLC and the Thermo Scientific Q Exactive BioPharma MS/MS Hybrid Quadropole-Orbitrap mass spectrometer in the last three years.
Agilent Technologies (US) held the second position in the global forensic equipment and supplies market. The company has a strong presence in major markets such as the US, Germany, Brazil, China, Japan, Australia, Canada, France, and Spain. To strengthen its current position and gain a larger share of the market, the company mainly focuses on product commercialization. For instance, the company launched the 7250 GC/Q-TOF system and the 6495B Triple Quadrupole LC/MS System in 2017. Agilent also focuses on other growth strategies such as market expansion and collaborations to build a competitive advantage.

Global Spinal Implants and Surgical Device Market - Key Growth Strategy Adopted by Leading Players

The key players in the spinal implants and surgical device market focus on various strategies such as new product launches and product enhancements; mergers and acquisitions; geographic expansions; and partnerships, agreements, and collaborations in order to strengthen their global position in the spinal implants and surgical devices market.
New product launches and product enhancements was the key growth strategy adopted by a majority of the industry players to increase their share the spinal implants and surgical devices market. Companies such as Medtronic, plc (Ireland), NuVasive, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V. (Netherlands), K2M Group Holdings, Inc. (U.S.), RTI Surgical, Inc. (U.S.) majorly adopted this strategy. Apart from product launches and enhancements, a number of leading players adopted the strategy of partnerships, agreements, and collaborations to strengthen their sales and distribution networks, generate additional product demand, and strengthen their positions in the spinal implants and surgical device market.
According to Research report the global spinal implants market is estimated to reach 17.27 Billion by 2021, at a CAGR of 5.3%
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712
On the basis of geography, the spine implant devices market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global spinal implants market is estimated to be dominated by North America. A number of factors such as high awareness about the newly developed treatment technologies, well-established healthcare infrastructure, increasing incidences of spinal disorders, growth in the aging and obese population, and rising government funding to support R&D of innovative spine treatment devices are driving the growth of the spinal implants market in the North American region. The Asia-Pacific spine implant devices market is expected to grow at the highest CAGR from 2016 to 2021. This is primarily due to the growing income levels, increasing government healthcare expenditure, presence of a large patient population, rising obesity cases, growing awareness about newly developed spine treatment techniques, and increasing investments by global market players in the emerging nations from Asia-Pacific region.
On the basis of technology, the global spinal implants market is segmented into three categories, namely, spinal fusion and fixation, vertebral compression fracture treatment, spinal decompression, and motion preservation/non-fusion technologies.
Based on the type of product, the spinal implants market is classified into seven segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, non-fusion treatment devices, spinal decompression devices, and spine bone stimulators.

Liquid Biopsy Market is projected to Reach USD 2,047.9 Million By 2022

The global liquid biopsy market is projected to reach USD 2,047.9 million by 2022 from USD 715.7 million in 2017, at a CAGR of 23.4%. The liquid biopsy market is a consolidated market with a large number of companies offering liquid biopsy instruments and accessories. In 2016, QIAGEN N.V. (Netherlands), Roche Diagnostics (US), and Illumina, Inc. (US) dominated the liquid biopsy market.
QIAGEN is the leading player in the liquid biopsy market in 2016. The company is a global provider of sample-to-insight solutions that aids in the transformation of biological samples into molecular insights. The company operates through its two business segments, namely, instruments and consumables & related products. QIAGEN provides solutions to more than 500,000 customers globally, in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing, and food safety), pharma (pharma and biotech companies), and academia (life sciences research). The company operates in the liquid biopsy market through its molecular diagnostics and life science tools customer base segment.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id= 13966350     Roche Diagnostics ranked second in the liquid biopsy market in 2016. Roche Diagnostics focuses on the discovery, manufacturing, and marketing of medical devices used to screen, diagnose, and monitor therapies. The company operates in the liquid biopsy market through its molecular diagnostics segment. The company geographically operates in Europe, the Middle East and Africa, North America, Asia Pacific, and Latin America.
Illumina ranked third in the liquid biopsy market in 2016. The company provides sequencing and array-based solutions for genetic analysis. The company develops, manufactures, and markets integrated systems and life science tools for the analysis of genetic variation and biological function. The company operates in the liquid biopsy market through its spinoff company “GRAIL Inc.”
Some of the other players competing in this market are Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), Pathway Genomics Corporation (US), ANGLE plc (UK), Vortex Biosciences (US), Epic Sciences (US), Cynvenio Biosystems Inc. (US), Personal Genome Diagnostics, Inc. (US), MedGenome Inc. (US), Exosome Diagnostics (US), NeoGenomics, Inc. (US), Foundation Medicine, Inc. (US), Sequenom, Inc. (US) MDxHealth SA (US), and Chronix Biomedical (US).

Urinalysis Systems Market- Size, Share, Trends| Global Forecast 2021

According to the new market research report "Urinalysis Systems Market” is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in 2016 at a CAGR of 7.6% from 2016 to 2021.
Get 278 market data Tables and 41 Figures spread through 223 Pages and in-depth TOC on "Urinalysis Systems Market- Forecast to 2021"
https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html
The major factors driving the growth of this market are rising prevalence of kidney diseases and urinary tract infections, implementation of PPACA, technological advancements, increasing adoption rate of point-of-care urinalysis devices, increasing healthcare expenditure and increasing geriatric population.
·        On the basis of product type, the Urinalysis Systems Market is segmented into consumables and instruments. Consumables are expected to account for the largest share of the market due to factors such as wide use of disposables in urinalysis testing and research, the introduction of new and advanced reagents & dipsticks and the utilization of disposables at a larger scale in the market.
·        On the basis of test type, the Urinalysis Systems Market is segmented into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis segment is expected to account for the largest share of the global Urinalysis Systems Market in 2016. The rapidly growing geriatric population and rising prevalence of kidney diseases and urinary tract infections are the key factors propelling the growth of this market.
·        On the basis of end user, the Urinalysis Systems Market includes hospitals and clinical laboratories, diagnostics laboratory, research laboratories and institutes and home care settings. The hospitals and clinical laboratories segment is expected to account for the largest share of the global Urinalysis Systems Market in 2016. Extensive use of dipsticks by hospitals and clinical laboratories is the major factors driving the growth of this market.
·        Based on applications, the global Urinalysis Systems Market is segmented into disease diagnostics and pregnancy tests. Disease diagnostics segment is expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by the factors such as advancement in the development of new urinalysis tests for better and early diagnosis of chronic diseases.
Download Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=153479294
Asia segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is driven by the factors such as rising demand for urine testing products, increasing healthcare expenditure, rising prevalence of diabetes, and growing geriatric population are driving the growth of the Urinalysis Systems Market in this region.
The key players in the Urinalysis Systems Market include Beckman Coulter (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Sysmex (Japan) and Arkray, Inc. (Japan).
Target Audience for this Report:
·        Urinalysis Product Manufacturers
·        Urinalysis Associations
·        Research and Consulting Firms
·        Distributors of Urinalysis Products
·        Contract Manufacturers of Global Urinalysis Products
·        Healthcare Institutes (Hospitals, Medical Schools, Diagnostic Centers, and Outpatient Clinics)
·        Research Institutes and Clinical Research Organizations (CROs)
·        Venture Capitalists
·        Insurance Providers (Payers)
·        Government Bodies

Medical Holography Market Dynamics and Global Forecast to 2021

The overall medical holography market is expected to grow from USD 163.4 million in 2015 to USD 953.9 million by 2021, at a CAGR of 33.7% from 2016 to 2021. Holography in medical science is mainly used to form 3D images of the human anatomy. Medical 3D holography is used to represent complex 3D structures beneficial for medical imaging, medical research, and medical training & education. The holography products covered in the study include holography displays, holography microscopes, holography prints, holography software, and holoscopes. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.
Market Dynamics
·        Drivers
o  Rising adoption of holography products in biomedical research and medical education
o  Growing clinical applications of holography
o  Emergence of holography as a promising technology in representing complex 3D structures
·        Restraints
o  High computational cost of processing holograms
·        Opportunities
o  Increasing investments in the digital holography market
·        Challenges
o  Technological limitations
o  Less effective projection under sunlight
Rising adoption of holography products in biomedical research and medical education drives the growth of the medical holography market.
Holography has emerged as one of the most promising tools for the medical industry. Holographic techniques have extended their applications in life sciences and medical research as well as medical education. The use of holographic imaging and projection has resulted in tremendous changes in the field of biomedical research and medical education and training.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183930222
In addition to medical imaging and research, holographic display technology and digital holograms are extensively used in the education industry and hospital teaching. 3D visualization through holography products create an interesting and interactive learning atmosphere as holography helps retain more information compared to other learning techniques. With growing focus on structural biology in medical schools, various market players are focusing on developing holographic prints and holography software to be used for medical teaching and training applications. Companies have developed a 3D kit for medical students and doctors that will help them practice surgeries and dissections without needing real bodies and organs. Echopixel, an emerging player in the medical holography market, launched True3D Viewer, a new generation of medical visualization software. This software converts anatomical data from patients into fully interactive, three-dimensional virtual reality images. With these innovations, medical holography is increasingly being used for healthcare research, hospital teaching, and medical education.
The growing applications of holographic techniques, coupled with their advantages, have encouraged their adoption in research labs, schools and universities, and hospitals across the globe.

Weight Loss and Weight Management Market Leading Players and Business Strategies

The weight loss and weight management market is expected to reach USD 245.51 billion by 2022 from USD 175.94 billion in 2017, at a CAGR of 6.9%. Increasing number of bariatric surgeries, growing rate of obesity, increasing prevalence of lifestyle diseases, and launch of new and advanced products are the factors driving the growth of the market.
Product launches accounted for the largest share of the overall growth strategies mapped from 2014–2017. Some of the leading players who adopted this strategy are Atkins Nutritionals (US), Brunswick (US), Nutrisystem (US), Weight Watchers (US), Amer Sports (Finland), Herbalife (US), and Johnson Health Technology (Taiwan).
Prominent players in the weight loss and weight management market, by diet, include Atkins Nutritionals, Inc. (Atkins) (US), Herbalife Ltd. (Herbalife) (US), Nutrisystem Ltd. (Nutrisystem) (US), and Kellogg Company (Kellogg) (US).
Ethicon, Inc. (Ethicon) (US), Covidien, plc. (Covidien) (US), Apollo Endosurgery (US), and Olympus Corporation (Olympus) (Japan) are some prominent players in the surgical equipment market, while Brunswick Corporation (Brunswick) (US), Amer Sports (Finland), Johnson Health Technology, Ltd. (Johnson Health Tech) (Taiwan), Cybex International (Cybex) (US), and Technogym SpA (Technogym) (Italy) operate in the fitness equipment segment.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1152
In 2016, Brunswick dominated the weight loss and weight management fitness equipment market. The company has managed to create a unique identity in this market due to its robust product portfolio and large geographic presence. In addition, the company focuses on adopting organic as well as inorganic growth strategies to maintain its leading position in the market. For instance, in May 2017, the company launched a new Integrity Series cardio line, including a Treadmill, Elliptical Cross-Trainer, and Upright and Recumbent Lifecycle Exercise Bikes. To leverage opportunities in the weight loss and weight management market, in January 2016, the company acquired Cybex (US) which expanded Brunswick’s portfolio of fitness products.
Technogym was the second leading player in the weight loss and weight management fitness equipment market in 2016. To maintain its leading position in the fitness equipment market, the company focuses on adopting organic as well as inorganic growth strategies. For instance, in November 2014, Technogym partnered with Talise, a member of the Jumeirah Group. Under this agreement, Technogym will supply fitness equipment to Talise Fitness Facilities. This agreement enabled the company to expand its customer base, thereby increasing its market presence in Middle Eastern countries. Furthermore, in January 2015, the company introduced its mywellness cloud, an open platform to collect personal fitness data in one location. This product enables users to collect data regarding their physical workouts from both inside and outside the gym. Such product launches enable the company to expand its product offerings in the fitness equipment market.

Oral Care Market Dynamics and Major Market Developments

According to research report oral care market is expected to grow from USD 41.56 billion in 2017 to USD 53.97 billion by 2023, at a CAGR of 4.5% from 2017 to 2022. Oral care products are used for the diagnosis, treatment, and prevention of dental diseases; maintenance of oral hygiene; or postoperative care. These products include toothbrushes, toothpastes, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthetic cleaning solutions. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Market Dynamics

Drivers

• Growing awareness on oral hygiene
• Technological advancements in oral care products
• Rising incidence of dental caries and other periodontal diseases

Restraints

• Competitive pricing pressure faced by prominent players

Opportunities

• Untapped emerging markets
• Increasing online purchase of oral care products

Challenges

• High dependence on retail stores

Key players considered in the analysis of the oral care market are Colgate-Palmolive Company (US), The Procter & Gamble Company (US), Unilever plc (UK), Koninklijke Philips N.V. (Netherlands), GlaxoSmithKline plc (UK), Johnson & Johnson (US), GC Corporation (Japan), Dr. Fresh, LLC (US), 3M Company (US), Young Innovation Inc. (US), Ultradent Products, Inc. (US), Lion Corporation (Japan), Henkel AG & Company, KGaA (Germany), Sunstar (Japan), and Kao Corporation (Japan).

Major Market Developments

• In August 2016, Colgate-Palmolive Company (US) launched the Cibaca Vedshakti toothpaste in India. This product costs INR 50 (USD 0.78) for 175 grams, which is around 30% cheaper than the Dant Kanti toothpaste, a product from Patanjali Ayurved Ltd. (a prominent local player in India).
• In 2016, Koninklijke Philips N.V. (Netherlands) introduced Sonicare FlexCare Platinum Connected electric toothbrush. This electric toothbrush is rechargeable and feature inbuilt ultrasonic technology, which aids the safe and effective removal of dental plaque and reduces the chances of gingival inflammation and bleeding.

Technological innovation in oral care products drives the growth of the oral care market.

Product innovation has enabled the development of technologically advanced and easy-to-use oral care products such as electrical toothbrushes and vibrators. Players such as The Procter & Gamble Company (US) and Koninklijke Philips N.V. (Netherlands) are increasingly focusing on innovation in the market. These players are focusing on the development of application-based toothbrushes and smart electric toothbrushes, which are connected to a smartphone with the Bluetooth technology. Recently, some major players launched interactive toothbrushes equipped with position detection and motion sensor technologies. These toothbrushes screen the oral cavity to provide a real-time guidance for brushing and maintaining oral health. The development of such innovative products enables users to track oral care habits and improve oral health. Owing to these advantages, end users are willing to spend more on advanced products; this, in turn, is expected to drive the growth of the market in the coming years.